Estonian Companies
English

Celvia CC AS

11673707

General info

Name

Celvia CC AS

Registry code

11673707

VAT number

EE101318989

Type

AS - Joint Stock Company

Status

Registered

Foundation date

12.08.2009 (15)

Financial year

01.01-31.12

Capital

25 756.00 €

Activity

86902 - Activities of medical laboratories, blood banks, sperm banks and other similar banks 72111 - Research and experimental development on biotechnology

Revenue

1 481 706 €

Profit

33 866 €

Profit margin

2%

Gross salary

2 320 €

(estimate is approximate)

Equity

476 626 €

Employees

35

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

7%

Return on assets

2%

Related parties

Owner Representative Beneficial owner Roles

Andres Salumets

19.05.1971 (53)

31% - 7 924.92 EUR Board member Member of a higher management body, i.e. board member or supervisory board member Shareholder

Kaarel Krjutškov

14.03.1981 (43)

15% - 3 962.46 EUR Board member - Shareholder

Asper Biogene OÜ

14265334

15% - 3 962.46 EUR - - Shareholder

Andrei Sõritsa

25.11.1961 (62)

- - - Board member

Ari Pekka Kalevi Sillanaukee

07.09.1964 (60)

- - - Board member

Jaanus Pikani

29.12.1959 (64)

- - - Board member

Ülle Jaakma

01.10.1957 (67)

- - - Board member

EESTI TÕULOOMAKASVATAJATE ÜHISTU

10064515

- - - Founder

Aktsiaselts Nova Vita Kliinik

10285009

- - - Founder

AS Viimsi Haigla

10391415

- - - Founder

aktsiaselts Biotehnoloogia Park Kinnisvara

10834232

- - - Founder

Bestenbalt OÜ

10874510

- - - Founder

AS Kliinik Elite

10911961

- - - Founder

osaühing TBD Pharmatech

11204964

- - - Founder

Tallinna Ülikool

74000122

- - - Founder

Tartu Ülikool

74001073

- - - Founder

Eesti Maaülikool

74001086

- - - Founder

Related companies

Owner Representative Beneficial owner Roles

Sen-Lab OÜ

14528578

- - - Founder

Financial info

2019
26.06.2020 		2020
29.06.2021 		2021
21.06.2022 		2022
30.06.2023 		2023
27.06.2024
Total Revenue 452 355 € 1 218 973 € 1 196 230 € 1 109 400 € 1 481 706 €
Net profit (loss) for the period 20 212 € 41 994 € 65 314 € 123 046 € 33 866 €
Profit Margin 4% 3% 5% 11% 2%
Current Assets 401 812 € 888 896 € 919 073 € 848 915 € 1 320 326 €
Fixed Assets 54 397 € 48 362 € 26 859 € 54 784 € 155 956 €
Total Assets 456 209 € 937 258 € 945 932 € 903 699 € 1 476 282 €
Current Liabilities 249 747 € 632 858 € 601 218 € 435 939 € 999 656 €
Non Current Liabilities - 50 000 € 25 000 € 25 000 € 0 €
Total Liabilities - 682 858 € 626 218 € 460 939 € -
Share Capital 25 756 € 25 756 € 25 756 € 25 756 € 25 756 €
Equity 206 462 € 254 400 € 319 714 € 442 760 € 476 626 €
Employees 20 27 28 28 35

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 178 384.32 € 135 358 € 145 705.34 € 44
2023 Q4 240 772.54 € 139 604.97 € 141 282.73 € 44
2023 Q3 346 138.66 € 118 221.75 € 127 617.92 € 51
2023 Q2 268 416.93 € 120 363.05 € 115 391.95 € 56
2023 Q1 157 714.03 € 103 158.15 € 110 731.75 € 51
2022 Q4 161 378.31 € 99 827.83 € 94 760.65 € 45
2022 Q3 76 321.6 € 90 695.12 € 96 014.09 € 39
2022 Q2 201 412.77 € 92 431.29 € 85 375.79 € 46
2022 Q1 110 461.07 € 111 183.52 € 119 015.93 € 48
2021 Q4 196 247.17 € 101 646.81 € 88 919.86 € 47
2021 Q3 71 992.45 € 87 228.92 € 90 559.28 € 48
2021 Q2 207 354.17 € 109 138.04 € 101 118.29 € 45
2021 Q1 341 674.16 € 101 920.71 € 98 064.26 € 48
2020 Q4 186 277.5 € 87 323.83 € 81 961.78 € 51
2020 Q3 140 736.46 € 80 829.01 € 76 358.75 € 47
2020 Q2 260 107.97 € 93 315.56 € 71 889.24 € 38
2020 Q1 96 815.49 € 62 106.76 € 62 242.83 € 35